A new method for producing therapeutic agents: can a breast cancer treatment be produced in plants?
Date
2012-12-10
Authors
Grohs, B.M.
Niu, Y.
Veldhuis, L.J.
et al
Institute for Community Engaged Scholarship
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
A system for producing pharmaceuticals in plants was tested using trastuzumab, which is a treatment for certain breast cancers in humans. When compared to its traditionally-made counterpart (Herceptin), the plant-produced trastuzumab had a similar structure, and was equally effective at inhibiting cancer cell growth in laboratory tests.
Description
This summary is a project of the Institute for Community Engaged
Scholarship (ICES) at the University of Guelph, with project partners:
the Business Development Office (BDO), SPARK Program at the
University of Guelph, and Knowledge Mobilization Unit at York
University. This project is part of the Pan-Canadian Research
Impact Network. http://csahs.uoguelph.ca/pps/Clear_Research
Keywords
breast cancer, HER2, therapeutic antibody, biopharming, Herceptin, trastuzumab